CJC-1295 with DAC, IPAM, GHRP-2 BLEND (2mg each = 6mg)

69,25 

Order in bulk and SAVE!
Order: 5 – 9 vials and SAVE 10%
Order: 10 – 19 vials and SAVE 15%
Order: 20 – 49 vials and SAVE 20%

*Bulk discount will be displayed in your shopping cart
**Don’t Forget the Sterile Water – Sold Here

Not-Available-Outside-the-U.S.

Description

Revo Peptide offers the CJC-1295 with DAC, Ipamorelin, and GHRP-2 Blend β€” three individually characterized research peptides co-lyophilized into a single vial at 2 mg each (6 mg total). Each vial is manufactured to β‰₯98% purity and verified by HPLC and mass spectrometry, making it a premium-grade research reagent for qualified laboratory environments. For research use only. Not for human or veterinary use. Not for clinical, diagnostic, or consumptive applications.

Product Overview

This triple-peptide blend consolidates three of the most widely studied growth hormone secretagogue-class compounds into a single, convenient lyophilized vial. CJC-1295 with DAC, Ipamorelin (IPAM), and GHRP-2 are each present at 2 mg per vial, yielding a combined 6 mg of research-grade peptide material. Revo Peptide formulates this blend to support streamlined in vitro and laboratory workflow, reducing the need for multiple separate vials during experimental protocols. Available for sale online with competitive pricing and reliable fulfillment.

Peptide Structure & Amino Acid Sequence

Each component of this blend carries a distinct molecular identity:

  • CJC-1295 with DAC: Molecular Formula C165H269N47O46 | Molecular Weight: 3647.19 g/mol | Sequence: H-Tyr-D-Ala-Asp-Ala-Ile-Phe-Thr-Gln-Ser-Tyr-Arg-Lys-Val-Leu-Ala-Gln-Leu-Ser-Ala-Arg-Lys-Leu-Leu-Gln-Asp-Ile-Leu-Ser-Arg-Lys(Mal)-NH2. The Drug Affinity Complex (DAC) modification extends the peptide’s half-life profile, a characteristic of significant interest in extended-duration research models.
  • Ipamorelin (IPAM): Molecular Formula C38H49N9O5 | Molecular Weight: 711.85 g/mol. A pentapeptide with selective growth hormone secretagogue receptor affinity, widely studied for its high specificity and favorable selectivity profile in laboratory settings.
  • GHRP-2 (Growth Hormone Releasing Peptide-2): Molecular Formula C45H55N9O6 | Molecular Weight: 817.94 g/mol. A hexapeptide research compound studied extensively for its role in GH secretagogue receptor binding and associated downstream signaling pathways in preclinical research models.

Chemical & Physical Characteristics

  • Appearance: White to off-white lyophilized powder
  • Solubility: Soluble in aqueous buffer systems (research-grade solvents only)
  • Storage Temperature: βˆ’20Β°C (long-term); 2–8Β°C (short-term, post-reconstitution in research settings)
  • Format: Co-lyophilized blend β€” 2 mg CJC-1295 with DAC + 2 mg Ipamorelin + 2 mg GHRP-2 per vial

Purity & Analytical Verification (HPLC & MS)

All three peptide components within this blend are independently verified to β‰₯98% purity prior to blending and lyophilization. Revo Peptide employs reverse-phase high-performance liquid chromatography (RP-HPLC) and electrospray ionization mass spectrometry (ESI-MS) as part of a rigorous batch-level analytical protocol. Certificate of Analysis (CoA) documentation is available upon request, confirming purity, identity, and molecular weight accuracy for each constituent compound.

Quality Control & Lyophilization Integrity

The lyophilization process is conducted under controlled conditions to preserve structural integrity, prevent peptide degradation, and ensure uniform distribution of all three components within each vial. Each batch undergoes multi-point quality control checks including moisture content assessment, visual inspection, and reconstitution behavior testing. Only vials meeting Revo Peptide’s strict release criteria are approved for sale and distribution.

Safety, Handling & Laboratory Precautions

This product is intended exclusively for use by trained research scientists and laboratory professionals in properly equipped facilities. Standard laboratory personal protective equipment (PPE) β€” including gloves, lab coat, and eye protection β€” should be worn at all times when handling lyophilized peptide material. Avoid inhalation of powder. This compound is not a pharmaceutical product and must not be used in any biological system outside of approved in vitro research contexts.

Reconstitution, Packaging & Storage

For in vitro laboratory reconstitution, research-grade sterile water or appropriate aqueous buffer is recommended, following institutional laboratory protocols. Store lyophilized vials at βˆ’20Β°C in a sealed, moisture-free environment away from direct light. Once reconstituted for laboratory use, store at 2–8Β°C and use within the timeframe established by your institutional research guidelines. Each vial is sealed under inert conditions to maximize shelf stability during shipping and storage.

Intended Research Use & Market Positioning

This blend is positioned as a high-value research reagent for laboratories investigating growth hormone secretagogue receptor (GHSR) biology, pulsatile GH signaling, and related neuroendocrine research pathways. The combination of CJC-1295 with DAC, Ipamorelin, and GHRP-2 in a single vial offers researchers a practical, cost-effective solution for multi-compound experimental designs. Revo Peptide supplies this blend to academic institutions, pharmaceutical research organizations, and independent research laboratories globally.

Ordering, Availability & Fulfillment

Order the CJC-1295 with DAC, Ipamorelin & GHRP-2 Blend online directly from Revo Peptide. Bulk pricing discounts are available at checkout β€” the more you order, the more you save. All orders are processed promptly, with secure packaging designed to maintain cold-chain integrity during transit. Buy online today and take advantage of our best price guarantee and fast dispatch to research destinations worldwide.

Legal & Regulatory Disclaimer

For research use only. Not for human or veterinary use. Not for clinical, diagnostic, or consumptive applications. This product is sold exclusively as a laboratory research reagent. It has not been evaluated by any regulatory authority for safety or efficacy in humans or animals. Revo Peptide assumes no liability for misuse of this product outside of its intended research application. Purchasers are solely responsible for ensuring compliance with all applicable local, national, and international laws and regulations governing the purchase, possession, and use of research peptides.

Reviews (0)

Reviews

There are no reviews yet.

Be the first to review “CJC-1295 with DAC, IPAM, GHRP-2 BLEND (2mg each = 6mg)”

Your email address will not be published. Required fields are marked *

Shipping & Delivery